Tatva Chintan Pharma Chem Dirección
Dirección controles de criterios 3/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Chintan Shah
Chief Executive Officer (CEO)
₹16.5m
Compensación total
| Porcentaje del salario del CEO | 30.8% |
| Permanencia del CEO | 27.8yrs |
| Participación del CEO | 23.8% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 15.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion
Apr 04
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts
Jan 26Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year
May 10Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next
Jul 28Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely
Jun 17Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings
May 03Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?
Dec 06Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹377m |
| Sep 30 2023 | n/a | n/a | ₹459m |
| Jun 30 2023 | n/a | n/a | ₹452m |
| Mar 31 2023 | ₹17m | ₹5m | ₹455m |
| Dec 31 2022 | n/a | n/a | ₹460m |
| Sep 30 2022 | n/a | n/a | ₹572m |
| Jun 30 2022 | n/a | n/a | ₹825m |
| Mar 31 2022 | ₹17m | ₹5m | ₹959m |
| Dec 31 2021 | n/a | n/a | ₹995m |
| Sep 30 2021 | n/a | n/a | ₹976m |
| Jun 30 2021 | n/a | n/a | ₹687m |
| Mar 31 2021 | ₹14m | n/a | ₹523m |
| Mar 31 2020 | ₹14m | n/a | ₹378m |
| Mar 31 2019 | ₹14m | n/a | ₹205m |
Compensación vs. Mercado: La compensación total ($USD197.94K) de Chintan está en línea con el promedio de empresas de tamaño similar en el mercado Indian ($USD275.56K).
Compensación vs. Ingresos: La compensación de Chintan ha sido consistente con los resultados de la empresa en el último año.
CEO
Chintan Shah (49 yo)
27.8yrs
Permanencia
₹16,503,252
Compensación
Mr. Chintan Nitinkumar Shah is the Managing Director and Chairman at Tatva Chintan Pharma Chem Limited and its Executive Director since June 12, 1996. He holds a bachelor’s degree in engineering, with a sp...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & MD | 27.8yrs | ₹16.50m | 23.84% ₹ 6.8b | |
| Whole Time Director | 27.8yrs | ₹16.50m | 24.01% ₹ 6.9b | |
| Whole Time Director | 27.8yrs | ₹16.50m | 24% ₹ 6.9b | |
| Non Executive Independent Director | 3.2yrs | ₹230.00k | sin datos | |
| Non Executive Independent Director | 3.2yrs | ₹250.00k | sin datos | |
| Non Executive Independent Director | 3.2yrs | ₹180.00k | sin datos |
15.5yrs
Permanencia media
50yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de TATVA son experimentados ( 15.5 años antigüedad media).